Upon completion of the distribution, Embecta will be an independent and publicly traded company focused on diabetes management that BD will retain no ownership interest.
The “test to treat” initiative enables people to get tested for COVID-19 at a pharmacy, and if they’re positive, receive antiviral pills on the spot at no cost.